Skip to content

NHS

Uncle Sam hitting a high striker with a large hammer. The high striker show a lambda at the top.

Cost-effectiveness thresholds under political pressure: where are the health economists?

The UK government is reportedly preparing to raise NICE’s cost-effectiveness threshold by 25%, as a bargaining chip to avoid US pharmaceutical tariffs. It’s time for health economists to reclaim this space and defend evidence-based decision-making.